Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02779556 · ClinicalTrials.gov registry record · NA
Health Literacy Intervention to Improve Diabetes Outcomes Among Rural Primary Care Patients
A NA study, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 756
- Enrollment target
NCT02779556: Completed NA study, sponsored by University of Arkansas.
NCT02779556 is a NA study that has completed, run by University of Arkansas. The registered enrollment target is 756 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (46% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02779556, a NA study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 756 participants
- Enrollment target
Study Summary
The researchers will conduct a patient-randomized, pragmatic clinical trial among 6 rural PCMHs in Arkansas, targeting individuals with uncontrolled type 2 diabetes. The primary aims are to: 1. test the effectiveness of the ACP diabetes health literacy intervention to improve a range of diabetes-related outcomes among rural patients; 2. compared to usual care, evaluate whether the intervention reduces disparities by patient literacy level. The secondary aims are to: 3. investigate whether a threshold or gradient effect exists between the amount of follow-up counseling (number of action plans) and intervention effectiveness; 4. determine the fidelity of all intervention components, and explore any identified patient, provider (physician, nurse, health coach), and/or health system barriers to implementation; and 5. assess the costs associated with implementing the intervention from a health system perspective.
Primary Outcome
HbA1C will be obtained from patients' electronic health records, defined as the value closest to 6 months post baseline. The hemoglobin A1c (HbA1c) value ranges from approximately 4 to 14% where higher HbA1c value means worse outcome.
Interventions
- OTHER ACP Living with Diabetes Guide
- OTHER ADA Living Well with Diabetes Workbook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 756 participants |
| Start Date | 2016-11-07 |
| Est. Completion | 2020-02-12 |
| Phase | NA |
What the finished NCT02779556 record still lists
NCT02779556 is an interventional study that assigns participants to a tested intervention. The registered 756 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (46% lower).
The record links to 0 conditions, and to 2 interventions - of which ACP Living with Diabetes Guide is the first listed.
NCT02779556 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02779556 about?
NCT02779556 is a clinical study titled "Health Literacy Intervention to Improve Diabetes Outcomes Among Rural Primary Care Patients". The researchers will conduct a patient-randomized, pragmatic clinical trial among 6 rural PCMHs in Arkansas, targeting individuals with uncontrolled type 2 diabetes. The primary aims are to: 1. test the effectiveness of the ACP diabetes health literacy intervention to improve a range of diabetes-r...
What is the current status of trial NCT02779556?
This trial is currently completed. It is a NA study. The enrollment target is 756 participants. The study started on 2016-11-07. Estimated completion is 2020-02-12.
What interventions are being tested in trial NCT02779556?
The interventions under investigation include: ACP Living with Diabetes Guide (OTHER), ADA Living Well with Diabetes Workbook (OTHER).
Who is sponsoring clinical trial NCT02779556?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02779556's enrollment target sits among peer trials
756 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05869149 · 756 participants · NA
Systems Science Approaches to Improve Access to Healthier Foods: The FRESH Trial
- NCT06095583 · 756 participants · Phase 3
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
- NCT05379985 · 754 participants · Phase 1
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- NCT05427370 · 754 participants · NA
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI